How a vaccine could prevent this debilitating women’s health condition
One in two women will experience a UTI in their lifetime – with one in four developing a chronic infection. Australian researchers are hoping to change this.
One in two women will experience a UTI in their lifetime – with one in four developing a chronic infection. Australian researchers are hoping to change this.
One in two women will experience a UTI in their lifetime – with one in four developing a chronic infection. Australian researchers are hoping to change this.
Experts warn of risks of platforms hosting bets tied to US public health – including vaccine mandates and drug trials
A Sydney hospital has contacted more than 2800 families after discovering babies and pregnant women were given incorrectly stored vaccines.
A Sydney hospital has contacted more than 2800 families after discovering babies and pregnant women were given incorrectly stored vaccines.
The vaccine that protects Australians from a serious bacterial infection is expected to run out this week.
Country is in the middle of worst measles outbreak since 1991, with more than 5,400 cases nationally
Experts have said the US-funded trial would deny critical vaccines to thousands of infants.
The trial was condemned as "unethical" and "neocolonial" because half of the babies would not be given the vaccine.
NY gov. pointed to Kennedy's long-standing anti-vaccine work as spurring outbreaks.
A young adult has been diagnosed with invasive meningococcal disease, South Australia's 22nd case this year.
A cancer vaccine has cut patients' risk of death by 42% in a global clinical trial
Kathmandu, Oct 27: Nepal is to receive vaccination support worth Rs 8.59 billion till 2030 under the Global Alliance for Vaccine and Immunisation (GAVI).
Nepal has secured Rs 8.59 billion in vaccine support from Gavi, the Vaccine Alliance, through 2030, providing a major boost to the country's routine immunisation programme at a time when global development funding is under increasing pressure.
In a rural corner of the US state of Pennsylvania, known for being home to the nation's largest Amish community, there is a scramble to contain one of the worst measles outbreaks in recent history.
A clinical trial begins to test the safety, efficacy and immunogenicity of multiple vaccines.
Merck and Moderna’s experimental mRNA vaccine cut the risk melanoma returned by 42%, opening a door for a new way to treat cancer. CNN’s Meg Tirrell reports.
Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful advance in melanoma treatment.